Rating History for Idera Pharmaceuticals (IDRA) by Barclays

More Stocks Rated by Barclays | Latest Ratings for IDRA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/19/2021 Gena Wang Downgrade Equalweight
(Overweight)		 2.00
(N/A)		 5.13
(0.43)		 -91.62% Details